single-molecule sequencing
Pacific Biosciences Reports 3 Percent Decrease in Q4 Revenues
Q4 revenues totaled $27.1 million, down from $27.9 million in Q4 of 2019 but beating the average Wall Street estimate of $25.4 million.
Pacific Biosciences to Obtain $900M Investment From SoftBank Subsidiary
The company plans to use the new funding, which will come from the sale of convertible senior notes due 2028, to support unspecified future growth initiatives.
PNAS Papers on Chemotherapy-Induced Cardiac Injury Target, Viral Insertions, SMRT Methylation Profiling
In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.
Nature Papers Include Monotreme Genomes, Single-Cell Study of Gastric Adenocarcinoma, More
In Nature this week: reference genomes for the platypus and echidna, single-cell RNA sequencing analysis of gastric adenocarcinoma, and more.
Startup Angstrom Bio Plans Saliva-Based COVID-19 Nucleic Acid Test on Nanopore Sequencing Platform
Premium
Angstrom Bio is developing a rapid, scalable coronavirus test that uses nanopore sequencing to detect barcoded PCR products.
Oct 8, 2020
Aug 3, 2020
Pacific Biosciences Q2 Revenues Drop 14 Percent
May 6, 2020
Pacific Biosciences Q1 Revenues Down 5 Percent
Feb 11, 2020
Feb 6, 2020
Pacific Biosciences Q4 Revenues Jump 43 Percent
May 3, 2019
Pacific Biosciences Q1 Revenues Fall 15 Percent
Mar 7, 2019